Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Parasitology medhauz CDB > Epidemiological Churva > Flashcards

Epidemiological Churva Flashcards

1
Q

Proportion of people suffering from disease at a given instant of time

A

Prevalence Rate:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

risk of developing disease per year

A

Incidence Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of mortality

risk of dying from a specific disease

A

Cause-specific Mortality Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk of dying for a specific age group

A

Age-Specific Mortality Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Killing power of a disease

A

Case Fatality Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

proportion of total deaths ascribed to a specific disease

A

Proportionate Mortality Rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

risk of a woman dying associated with pregnancy, delivery and puerperium

A

Maternal Mortality Rate:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stillbirth or fetal mortality rate:

A

risk of losing the product of conception before delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

risk of dying during first year of life

A

Infant Mortality Rate:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sum of stillbirth and neonatal death rates

A

Perinatal Mortality Rate:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Study of the distribution of disease or physiological condition in human population and of the factors that influence this distribution” (Lilienfeld, 1976)

A

EPIDEMIOLOGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

groups of people which may be defined by geographic boundaries or characteristics or attributes (e.g. age, gender)

A

Population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

occurrence of disease or condition

A

Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

variable responsible for the observed distribution of the condition (e.g. drinking of alcohol among adolescents – factors: self-efficacy and family function)

A

Factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

John Graunt

A

Collected and organized Bills of Mortality
• Identified broad causes of mortality: acute and “chronical diseases”
• Constructed the first known life table from collected data
DEMOGRAPHY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

James Lind (1747)

A

etiology and treatment of scurvy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Daniel Bernoulli

A

1760-Epidemiolgic analysis on smallpox inoculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pierre Charles-Alexandre Louis

A

One of first modern epidemiologists

Pioneered in emphasizing statistical methods in medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

First to use vital statistics and other demographic data for epidemiologic purposes.

Developed the concept of mortality surveillance

A

William Farr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Robert Koch. (1883)

A

identified the cholera vibrio.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

William Budd

A

typhoid fever

  • Argued against the miasmatic origin of typhoid fever
  • Inferred that typhoid fever was a “contagious and self-propagating fever”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Edgar Sydenstricker

A

Extensive epidemiologic studies identified the etiology of pellagra and made it possible to develop interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

role of cigarette smoking in the epidemic of lung cancer.

A

Bradford Hill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Harold Dorn

A

Sought to use the First National Cancer Survey as basis for an epidemiologic profile of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

• The study of the amount & distribution of disease within a population by person, place & time

A

Descriptive Epidemiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cross-sectional or Survey Studies

A

• Ad-hoc Survey: Special Surveys to establish incidence and prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Analytic Epidemiology

A

Study of the determinants of disease or reason for relatively high or low frequency of disease in specific groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Types of Analytic Studies

Cohort studies in which the groups to be studied are defined in terms of whether they are not exposed to the suspected factors are followed for a period of time to determine the frequency (Incidence) of the alleged effect (Disease) among them (Exposed) and not exposed

A

Concurrent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Types of Analytic Studies

Cohort studies in which both exposure and the effect have occurred prior to the tie of investigation

A

Non-concurrent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

affects utilization of medical care services for a variety of reasons:
o Limited financial reasons
o Restricted access to medical care
o Tend to underutilize available preventive service

A

Poverty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

OCCUPATION HAZARD

Pulmonary fibrosis

A

silica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

OCCUPATION HAZARD

Mesothelioma, lung CA, GIT CA

A

asbestos exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

aniline dyes

A

Bladder CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

chromate worker

A

Lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Blood type: A - risk of

A

gastric CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

O - more likely to have

A

duodenal ulcer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Three major kinds of change with time:

A
  1. Secular trends
  2. Cyclic change
  3. Clustering in time
38
Q

SECULAR TRENDS

A

Long term variations over a period of time, years or decades
• Ex. Cancers: lung cancer, breast cancer
• *Death closely parallel incidence rates only if the disease is fatal and if death happens nearly after diagnosis

39
Q

CYCLIC CHANGE

A 
Recurrent alterations in the frequency of diseases cycles maybe annual / seasonal or may have some other periodicity
Examples:​
o Measles
o Influenza A epidemic: every 2-3 yrs.
o Influenza B: every 4-6 yrs.
40
Q

CLUSTERING IN TIME

A

Epidemic: reported number of cases exceeds expected or unused number for that period

41
Q

Occurrence of more cases of disease than expected in a given area among a specific group of people over a particular period of time or two or more linked cases of the same illness

42
Q

An assertion or proposition about the relationship between 2 or more variables, adopted to explain facts and to guide in the investigation of others; supposition arrived at from observation or reflection that leads to refutable predictions

A

Hypo thesis

43
Q

STUDY DESIGNS

Descriptive Studies

A
  1. Case-Report
  2. Case-Series
  3. Cross-Sectional
  4. Ecologic Studies
44
Q

STUDY DESIGNS :

Analytic Studies

A
  1. Observational – Cohort, Case-Control, Cross-Sectional

2. Experimental – Clinical Trials, Community Trials

45
Q

describe only those with the disease

A

Case-Report and Case-Series

46
Q

Ecologic Studies –

A

data being used are secondary on population aggregates

47
Q

investigator simply observes the natural course of events, noting who is exposed and (who is not exposed) and who has not developed the outcome of interest

A

Observational Studies

48
Q

the members of the population at risk are classified in terms whether they had been exposed or unexposed to the factor of interest and followed up to determine who will develop the disease/condition being investigated

FOLLOWED UP

A

Cohort Studies

49
Q

identifies a group of subjects who already have the disease/condition and a comparison group who do not have the disease/condition. Information on past exposure are then obtained and compared between the cases and controls

COMPARISON

A

Case-Control Studies –

50
Q

measurements of cause and effect related to the same point in the study members’ lives; limited to studies of causes that are long standing characteristics of the individual

CAUSE AND EFFECT

A

Cross-Sectional Studies

51
Q

the investigator assigns the study subjects to the exposure status usually in a random manner

A

Experimental Studies

Notes

    1. Clinical Trials – individual subjects
    1. Community Trials – among population groups
52
Q

✓ Health gap measure that extends the concept of potential years of life lost due to premature death (PYLL) to include equivalent years of “healthy” life lost by virtue of being in states of poor health or disability
✓ Calculated as the sum of the years of life lost due to premature mortality (YLL) in the population and the years lost due to disability (YLD)

A

DALY (Disability Adjusted Life Year)

53
Q

Removal of agent from environmental or minimizing the amount of agent present
▪ Protection of the susceptible host from exposure

A

PRIMARY PREVENTION

54
Q

Screening tests

A

SECONDARY PREVENTION

55
Q

~Lifestyle modification (and rehab)

A

TERTIARY PREVENTION

56
Q

• The ability of an agent to invade and multiply (produce infection) in a host

A

INFECTIVITY

57
Q

Minimum number of particles or agents required to establish infection in 50% of a group of hosts of the same species

58
Q

Ability to produce clinically apparent illness in an infected population

= # of infected persons with disease
—————————————————-
Total number of infected persons

A

PATHOGENICITY

> Factors that may affect pathogenicity:
✓ Host and environmental factors
✓ Dose, route of entrance of infection, source of infection

59
Q

The extent to which severe disease is produced in a population with clinically manifest disease

Proportion of clinical cases resulting in severe clinical manifestations

60
Q

Determined How much of the afflicted die from the disease

A

CASE FATALITY RATE

# Of deaths from a specified cause
                 # Of cases of the same disease​   X 100
61
Q

-Capacity of an agent to produce a toxin or poison

• Disease results from the toxin produced by the agent rather than from the agent itself

A

TOXIGENICITY

62
Q

• Infection’s ability to produce specific immunity in the host (e.g. measles)

A

IMMUNOGENICITY

May be humoral immunity, cellular immunity or both
• Affected by host factors: age, nutrition, dose, and virulence
• May produce local immunity only—agents that replicate in local areas: rhinoviruses, gonococci
• Agent’s differ in intrinsic ability to induce an effective, lasting immune response

63
Q

A living organism or inanimate matter in which an infectious agent normally lives and multiplies.

A

RESERVOIR

Notes:

Reservoir is an essential component of the cycle by which an infectious agent maintains and perpetuates itself
• The specific reservoir for an agent is thus intimately related to the life cycle of that agents

64
Q

Zoonosis

A

infectious diseases that have vertebrate animal reservoirs; they are potentially transmissible to humans under natural conditions

65
Q

any person or animal that harbors a particular infectious agent without discernible clinical disease and serves as a potential source of infection

66
Q

infection present on surface of body—organism propagating at a rate sufficient to maintain its numbers without producing identifiable eveidence of any reaction in host

A

Colonization

67
Q

organism not only multiplying but also causes a measurable reaction that is however not clinically detectable

A

Inapparent or subclinical infection

68
Q

organism causes clinically detectable reaction

A

Symptomatic infection

69
Q

Considered direct transmission because these are heavy so they do not tend to travel more than 6 feet from the infected person
- A susceptible person who is not near an infected person will not become infected

A
  • droplets spread

- The spread of disease by respiratory droplets usually requires extended contact

70
Q

Period between receipt of infection by the host and maximal communicability of that host
• Roughly equivalent to incubation period

A

Generation Time

71
Q

Immunity of a group or community

• Resistance of a group to invasion because of the high proportion of immunized members of the group

A

Herd immunity

72
Q 
SAR=         # new cases in a group-initial cases
                   ————————————————————-
        # Of susceptible persons in group-initial cases
A

Secondary attack rates

73
Q

Latency Period ?

Incubation Period?

A

the time between infection agent and onset of infectiousness

the time between infection and onset of symptoms

74
Q

*Refers to Minimum proportion (p) of population that needs to be immunized in order to obtain herd immunity
• Important concept for immunization programs and eradiation of an infectious disease

A

HERD IMMUNITY THRESHOLD

75
Q

Number of current cases per population at risk

  • Old: persistent active disease contracted previously
  • New: onset of active disease
A

DISEASE PREVALENCE RATE

76
Q

Prevalence at a specific point in time?

Prevalence over a given time interval?

A

Point prevalence

Period prevalence
- - Prevalence over a given time interval
• Usage:
➢ Measure amount of illness in the community
➢ Determine health care needs of the community

77
Q

Number of new disease cases per population at risk
- High incidence implies high disease occurrence
- Low incidence implies low disease occurrence
• Measured over a given time interval

A

DISEASE INCIDENCE RATE

Usage:
➢ Determine probability of developing a specific disease
➢ Used to detect etiologic factors

78
Q

Estimates the probability of the population being ill at the period of time being studied

Useful in the study of the burden of chronic diseases and implication for health services

A

PREVALENCE

79
Q

Expresses the risk of becoming ill

The main measure of acute diseases or conditions; but also used for chronic diseases

Most useful for studies of causation

80
Q

➢ Refers to the proportion of the population who developed the disease in a given interval of time
➢ For investigating etiologic factors
➢ A measure of the risk of developing the disease in the population at risk of the disease

A

Incidence Measures

81
Q

Can be computed if all the members of the population are followed up for the same period of time

A

Cumulative Incidence

82
Q

➢ Numerator – still the number of new cases over the specified period of time
➢ Denominator – the accumulated person-time observation or follow-up time

A

Incidence Rate or Incidence Density

83
Q

➢ Measures the impact of mortality in a population
➢ Tells how fast deaths are occurring in a specific population
➢ Used to compare mortality in different populations or groups of individuals

A

Crude Death Rate

84
Q

➢ Special type of specific death rate
➢ Numerator – includes those who die of a certain disease
➢ Denominator – includes the number of cases of the said disease

A

Case Fatality Rate

         # of deaths from specific cause
 =      —————————————————
        # of cases of same specific cause
85
Q

➢ The proportion of all deaths that is attributed to this cause
➢ Measures the relative contribution of a specific cause to the deaths in a population
➢ Used for comparing the importance of causes of death within a population

A

Proportionate Mortality Rate

PMR = # of death of specific cause
———————————————
# of cases of same specific cause

86
Q

➢ Single (summary) measures that are computed for the population
➢ Obtained by dividing the number of cases (diseased individuals or deaths) by the size of the population form where these cases come from in a specified period of time

A

Crude Rates

87
Q

➢ Measures that are derived for subgroups of the population
➢ More suitable for comparisons of two different populations
➢ Computed in the same manner as crude rates except that the items counted in the numerator and denominator are limited to those who meet the criteria for membership in the subgroup
➢ Ex. Mortality rate among children 1-4 years old

A

Specific Rates

88
Q

➢ Measures how fast individuals in a population are dying from a specific cause

A

Cause specific death rate

Death from specific cause
——————————————
Total population

89
Q

➢ Used for comparing populations that have different distributions
➢ Ex: death rate of males

A

Death Rate for Specific Subgroup

90
Q

• Single summary measures that have been adjusted for the purpose of removing the effects of differences in the populations (e.g. age differences) when comparing these populations

A

Adjusted Rates

91
Q

Methods of Adjusting Rates

A
  1. Direct Standardization
    ➢ Uses the distribution (according to the variable of adjustment) of the standard population and computed an adjusted (or standardized) rate
    ➢ Used for adjusted comparisons
    ➢ Derived by dividing the total expected deaths by the total population of the standard
  2. Indirect Standardization
    ➢ Makes use of standard population also
    ➢ If age is the variable for adjustment, the age-specific rates in the standard population are employed (these rates are then multiplied to the age-specific population sizes of the population under study to arrive at the expected number of cases in this population
           Observed # of cases SMR =  ————————————-
      Expected # of cases

Parasitology medhauz CDB (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions